Seventy-four participants, with type 1 (T1D, n = 24), type 2 (T2D, n = 11), or gestational (n = 39) diabetes, were enrolled across 13 sites (9 in United Kingdom, 4 in Austria). The aim of this study was to determine accuracy (compared to self-monitoring of blood glucose ), clinical safety, and acceptability of the FreeStyle Libre System when used at home by this population. DOI: 10.32364/2587-6821-352-357.Īccuracy of the FreeStyle Libre™ Flash Glucose Monitoring System has not been evaluated in pregnant women with diabetes. Potentialities of modern glucose monitoring devices during pregnancy. This will improve the management of pregnant women with carbohydrate metabolism disorders.KEYWORDS: diabetes, gestational diabetes, continuous glucose monitoring, flash monitoring, pregnancy, macrosomia, self-monitoring.FOR CITATION: Ushanova F.O., Demidova T.Yu. Further studies on the potential use of these devices in gestational diabetes could provide a basis for increasing their application in routine clinical practice. ![]() As to gestational diabetes, the eligibility of modern glucose monitoring technologies for the prevention of various complications is still controversial. Multiple studies demonstrate the efficacy of CGM in terms of compensating manifest diabetes. The analysis of CGM data allows for correcting insulin therapy, taking a decision on its initiation, and modifying diet and exercise plan. CGM in pregnant women provides the detailed information on the type and trends of the changes in blood glucose levels and the fluctuations of glucose levels and also identifies the episodes of latent nocturnal hypoglycemia and postprandial hyperglycemia. In addition to the conventional methods of self-monitoring, continuous glucose monitoring (CGM) is an important tool to control diabetes. All rights reserved.Currently, the management of pregnant women with carbohydrate metabolism disorders is challenging due to the high risk of unfavorable events both for the mother and the child even in insignificant deviations from the target value. HbA1c cardiovascular flash blood glucose monitoring glycaemic control type 1 diabetes.Ĭopyright © 2020 Wolters Kluwer Health, Inc. The technology provides significantly more data than the intermittent results obtained by traditional subcutaneous blood glucose monitoring, which may not capture intervals of extreme variability or nocturnal events. After the 6-month follow-up, two 2/92 users did not wish to continue with the monitoring.įlash glucose monitoring has great potential for the management of type 1 diabetes in the adult population and improving metabolic control/quality of life for people across the world. There was also a narrowing of the distribution of HbA1c, with many fewer people running high HbA1c ≥80 mmol/mol (9.5%). In 92 consecutive users, HbA1c decreased by an average of 10.7 mmol/mol (0.98%) after 3 months, and by 16.1 mmol/mol (1.47%) after 6 months. ![]() The mean cohort age was 43 years for men and 39 years for women (overall range 17-83 years). An HbA1c of 60 mmol/mol (7.6%) was taken as the threshold for suboptimal glycaemic control. Initiation was with education and support from one of the diabetes specialist nurses. We report the outcomes of 92 consecutive adults (18 years of age or more) with type 1 diabetes who have begun using the FreeStyle Libre flash glucose monitor in East Cheshire, UK. We describe here how use of the FreeStyle Libre flash monitor has improved the glycaemic control of many people with type 1 diabetes where the new technology has been intensively deployed. Many people with type 1 diabetes continue to run high HbA1c levels with associated elevated risk of cardiovascular events and increased mortality.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |